Cargando…
Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment
BACKGROUND AND OBJECTIVE: Treatment for attention deficit hyperactivity disorder (ADHD) requires a multifaceted approach including psychosocial interventions and pharmacological treatment. This study evaluates preferences for specific attributes associated with different long-acting stimulant treatm...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158042/ https://www.ncbi.nlm.nih.gov/pubmed/34054292 http://dx.doi.org/10.2147/PPA.S311836 |
_version_ | 1783699802550173696 |
---|---|
author | Cambron-Mellott, M Janelle Mikl, Jaromir Matos, Joana E Erensen, Jennifer G Beusterien, Kathleen Cataldo, Marc J Hallissey, Bernadette Mattingly, Gregory W |
author_facet | Cambron-Mellott, M Janelle Mikl, Jaromir Matos, Joana E Erensen, Jennifer G Beusterien, Kathleen Cataldo, Marc J Hallissey, Bernadette Mattingly, Gregory W |
author_sort | Cambron-Mellott, M Janelle |
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Treatment for attention deficit hyperactivity disorder (ADHD) requires a multifaceted approach including psychosocial interventions and pharmacological treatment. This study evaluates preferences for specific attributes associated with different long-acting stimulant treatment among US adults with ADHD. METHODS: Patients completed an online, cross-sectional survey, incorporating a discrete choice experiment to assess preferences for attributes. RESULTS: Analyses included 200 adults with ADHD (mean age 33.0 years; 60% self-reporting moderate severity); the mean (SD) Adult ADHD Self-Report Scale-v1.1 score was 45.9 (12.4). Overall, patients valued speed of onset most and risk of rebound least. Three population groups with distinct preferences were identified: side effect-driven (n=69, 35%), quick onset-driven (n=47, 24%) and quick onset and long duration-driven (n=84, 42%). CONCLUSION: This study shows differences in how adults with ADHD value and assess benefit-risk trade-offs when considering the desired attributes of stimulant treatments, highlighting the importance of patient-physician shared decision-making to optimize the desired benefits of individualized treatment. |
format | Online Article Text |
id | pubmed-8158042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-81580422021-05-28 Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment Cambron-Mellott, M Janelle Mikl, Jaromir Matos, Joana E Erensen, Jennifer G Beusterien, Kathleen Cataldo, Marc J Hallissey, Bernadette Mattingly, Gregory W Patient Prefer Adherence Original Research BACKGROUND AND OBJECTIVE: Treatment for attention deficit hyperactivity disorder (ADHD) requires a multifaceted approach including psychosocial interventions and pharmacological treatment. This study evaluates preferences for specific attributes associated with different long-acting stimulant treatment among US adults with ADHD. METHODS: Patients completed an online, cross-sectional survey, incorporating a discrete choice experiment to assess preferences for attributes. RESULTS: Analyses included 200 adults with ADHD (mean age 33.0 years; 60% self-reporting moderate severity); the mean (SD) Adult ADHD Self-Report Scale-v1.1 score was 45.9 (12.4). Overall, patients valued speed of onset most and risk of rebound least. Three population groups with distinct preferences were identified: side effect-driven (n=69, 35%), quick onset-driven (n=47, 24%) and quick onset and long duration-driven (n=84, 42%). CONCLUSION: This study shows differences in how adults with ADHD value and assess benefit-risk trade-offs when considering the desired attributes of stimulant treatments, highlighting the importance of patient-physician shared decision-making to optimize the desired benefits of individualized treatment. Dove 2021-05-21 /pmc/articles/PMC8158042/ /pubmed/34054292 http://dx.doi.org/10.2147/PPA.S311836 Text en © 2021 Cambron-Mellott et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Cambron-Mellott, M Janelle Mikl, Jaromir Matos, Joana E Erensen, Jennifer G Beusterien, Kathleen Cataldo, Marc J Hallissey, Bernadette Mattingly, Gregory W Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment |
title | Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment |
title_full | Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment |
title_fullStr | Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment |
title_full_unstemmed | Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment |
title_short | Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment |
title_sort | adult patient preferences for long-acting adhd treatments: a discrete choice experiment |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158042/ https://www.ncbi.nlm.nih.gov/pubmed/34054292 http://dx.doi.org/10.2147/PPA.S311836 |
work_keys_str_mv | AT cambronmellottmjanelle adultpatientpreferencesforlongactingadhdtreatmentsadiscretechoiceexperiment AT mikljaromir adultpatientpreferencesforlongactingadhdtreatmentsadiscretechoiceexperiment AT matosjoanae adultpatientpreferencesforlongactingadhdtreatmentsadiscretechoiceexperiment AT erensenjenniferg adultpatientpreferencesforlongactingadhdtreatmentsadiscretechoiceexperiment AT beusterienkathleen adultpatientpreferencesforlongactingadhdtreatmentsadiscretechoiceexperiment AT cataldomarcj adultpatientpreferencesforlongactingadhdtreatmentsadiscretechoiceexperiment AT hallisseybernadette adultpatientpreferencesforlongactingadhdtreatmentsadiscretechoiceexperiment AT mattinglygregoryw adultpatientpreferencesforlongactingadhdtreatmentsadiscretechoiceexperiment |